review · 2015
Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox–Gastaut syndrome
Clobazam is the newest medication approved by the US Food and Drug Administration (FDA) for the treatment of Lennox-Gastaut syndrome (LGS) in patients at lea...
16 citationsDOI: https://doi.org/10.2147/tcrm.s55930Open accessPDF reported by metadataFull text reported by metadata